Composition for preventing or treating lung disease comprising hyaluronic acid and proteoglycan connexin 1
Relates to a recombinant hyaluronic acid and proteoglycan linked protein 1 (hyaluronan and proteoglycan link protein 1), and a preparation method of the recombinant hyaluronic acid and proteoglycan linked protein 1 (hyaluronan and proteoglycan link protein 1). The present invention relates to a comp...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
02.12.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Relates to a recombinant hyaluronic acid and proteoglycan linked protein 1 (hyaluronan and proteoglycan link protein 1), and a preparation method of the recombinant hyaluronic acid and proteoglycan linked protein 1 (hyaluronan and proteoglycan link protein 1). The present invention relates to a composition for preventing or treating lung diseases, which comprises, as an active ingredient, at least one selected from the group consisting of a HAPLN1 (hyaluronic acid and proteoglycan connexin 1) protein, a gene encoding the HAPLN1 protein, and an effective agent that promotes the expression of the HAPLN1 protein or gene or activates the function thereof, and a composition for preventing or treating lung diseases. The recombinant HAPLN1 protein according to the present disclosure has an excellent effect of improving alveolar injury caused by aging or elastin reduction, and thus can effectively prevent or treat lung diseases such as chronic bronchitis, asthma, emphysema, and chronic obstructive lung diseases.
涉及一种 |
---|---|
Bibliography: | Application Number: CN202180001405 |